REFERENCES
- D'Cruz CA, Wimmer RS, Harcke T, Huff DS, Naiman JL. Veno-occlusive disease of the liver in children following chemotherapy for acute myelocytic leukemia. Cancer. 1983;52:1803–1807.
- Roulet M, Laurini R, Rivier L, Calame A. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. J Pediatr. 1988;112:433–436.
- Jones RJ, Lee KSK, Beschorner WE, et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44:778–783.
- Kao NL, Rosenblate HJ. 6-thioguanine therapy for psoriasis causing toxic hepatic veno occlusive disease. J Am Acad Dermata 1993;28:1017–1018.
- Gill RA, Onstad GR, Cardamone JM, Maneval DC, Sumner HW. Hepatic veno-occlusive disease caused by 6-thioguanine. Ann Intern Med. 1982;96: 58–60.
- Satti MB, Weinbren K, Gordon-Smith EC. 6-Thioguanine as a cause of toxic veno-occlusive disease of the liver. J Clin Patho/. 1982;35: 1086–1091.
- Krivoy N, Raz R, Carter A, Alroy G. Reversible hepatic veno-occlusive disease and 6-thioguanine (letter). Ann Intern Med. 1982;96:788.
- Griner PF, Elbadawi A, Packman CH. Veno-occlusive disease of the liver after chemotherapy of acute leukemia: report of two cases. Ann Intern Med. 1976;85:578–582.
- Clark PA, Hsia YE, Huntsman RG. Toxic complications of treatment with 6-mercaptopurine: two cases with hepatic necrosis and intestinal ulceration. BMJ1960;1: 393–395.